Pooled Analyses of Total Symptom Score (TSS) Responses in Patients with Myelofibrosis (MF) Treated with Pacritinib (PAC) Vs Best Available Therapy (BAT) in Phase 3 Studies (PERSIST-1, PERSIST-2)
Year: 2018
Type: conference-abstract
Source: Blood
Institutions: The University of Texas at San Antonio Health Science Center, Hospital Clínic de Barcelona, Guy's and St Thomas' NHS Foundation Trust, Churchill Hospital, University of Florence, The University of Texas MD Anderson Cancer Center, CTI BioPharma (United States), Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Language: English
Subfield: Genetics (clinical)
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2907176303